AOAC Approves New Microbial Testing Validations

In a press launch despatched out this month, bioMérieux introduced they’ve obtained the very first approvals in hashish and hemp for AOAC Analysis Institute Efficiency Testing Strategies (PTM). AOAC accepted technique validation for the detection of Salmonella and STEC (Shiga toxin-producing E. coli) in hashish flower using bioMérieux GENE- UP® SLM2 (PTM 121802) and EHEC (PTM 121806) assays.

In accordance with the press launch, these validations are the primary of their sort within the hashish and hemp industries. The AOAC-validated testing strategies are accepted for 1-gram and 10-gram samples.

Dr. Stan Bailey, senior director of scientific affairs at bioMérieux, says these approvals show the corporate’s dedication to revolutionary and validated science within the hashish and hemp industries. “We are especially proud that the GENE-UP SLM2 and EHEC are the first two AOAC approvals in the United States for cannabis and hemp,” says Dr. Bailey. “This is increasingly important with now over half the population of the US living in states that have approved cannabis for recreational use and most states approving cannabis for medical use.”

The AOAC PTM designations are acknowledged by the US Division of Agriculture, the Meals and Drug Administration, and international regulatory companies. The validation steering builds on AOAC’s Hashish Analytical Science Program (CASP).

bioMérieux is a French in vitro diagnostics firm that serves the worldwide testing market. They supply diagnostic options equivalent to programs, reagents, software program and companies.